WOKING, United Kingdom, March 20, 2025 /PRNewswire/ — IDBS, a provider of cloud software for BioPharma companies, is thrilled to announce that it has been awarded the Best Bioprocessing Supplier Award: Software, at the prestigious Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. This recognition highlights our outstanding contributions to advancing BioPharma excellence in the Asia-Pacific region. The accolade, determined by the votes of over 10,000 professionals from 500+ entries, 300+ industry leaders, 150+ companies, and 50+ countries in the bioprocessing, logistics and supply chain management, ADC and clinical trials sectors across the Asia-Pacific region, underscores IDBS’ significant contribution to digital transformation in the life sciences industry.
The Asia-Pacific Biopharma Excellence Awards 2025 seeks to recognize exceptional Asian bioprocessing, logistics and supply chain management, ADC and clinical trials experts, organizations and technologies over the past year. By recognizing outstanding achievements of top BioPharma leaders, the awards applaud extraordinary leaders and trend-setters of today and inspire innovators of tomorrow.
“We are incredibly honored to receive this award,” said Pietro Forgione, General Manager of IDBS. “This recognition from our industry peers highlights the dedication of our team to advancing digitalization within biologics. We are committed to continuing our efforts to provide innovative solutions that enhance quality and efficiency for our customers.”
The awards ceremony took place on March 12th at the Sands Expo & Convention Centre, Singapore, in conjunction with the 12th Annual Biologics Manufacturing Asia 2025, the 9th Biologistics World Asia, and the Clinical Trial Festival Asia. This prestigious event brought together over 1300+ industry leaders and pioneers to celebrate significant achievements in the BioPharma sector.
Lear more about the award here.
About IDBS
IDBS helps BioPharma organizations unlock the potential of AI/ML to improve the lives of patients. As a trusted long-term partner to 80% of the top 20 global BioPharma companies1, IDBS delivers powerful cloud software and services specifically designed to meet the evolving needs of the BioPharma sector.
IDBS, a Danaher company, leverages 35 years of scientific informatics expertise to help organizations design, execute and orchestrate processes, manage, contextualize and structure data and gain valuable insights throughout the product lifecycle, from R&D through manufacturing. Known for its signature IDBS E-WorkBook software, IDBS has extended its flexible, scalable solutions to the IDBS Polar and PIMS cloud platforms to help scientists make smarter decisions with assured confidence in both GxP and non-GxP environments.
Visit idbs.com, to learn more about IDBS.
MEDIA ENQUIRIES
e | mediaenquiries@idbs.com
SOURCE IDBS
Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today…
Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…
Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…
Total Revenue Expected to be $276 Million MACI Revenue Expected to be $239.5 Million Fourth…
Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…
Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…